Orbillion Scales Cultivated Beef Production Across Three Continents

Orbillion has successfully scaled its cultivated beef production across North America, Europe, and Asia. This milestone cements Orbillion’s leadership in sustainable food technology and marks a major breakthrough in overcoming the challenges that have held back the commercialization of cultivated meat.

To strengthen its growth trajectory, Orbillion has also welcomed Dr. Thomas Beck, a seasoned food industry leader from Nestlé and DSM, to its Board of Directors—bolstering expertise as the company advances toward revenue.

Leading Cultivated Beef Innovation on Global Stages

This fall, Orbillion CEO Patricia Bubner presented the company’s technical advancements at NY Climate Week, GITEX Dubai, and Slush Helsinki. These events spotlighted Orbillion’s commitment to making cultivated beef commercially viable at a global level.

Unlike other companies that rely on fibroblasts, genetic modification, or lengthy cell adaptation processes, Orbillion is the only company scaling real muscle and fat cells without genetic modification (non-GMO). Its revolutionary bioware platform allows cells to move directly from biopsy to scale-up—reducing development time by 18 months and cutting costs by up to $11M.

“This achievement is revolutionary—not just for Orbillion, but for the future of food,” said Samet Yildirim, CTO of Orbillion. “Direct scaling of beef muscle and fat cells without GMO, serum, or expensive growth factors allows us to deliver the most tasty, sustainable, and cost-effective cultivated meat the world has ever seen.”

Overcoming Barriers in Cultivated Meat Production

The commercialization of cultivated meat faces significant hurdles, particularly because traditional bioprocesses from the pharmaceutical sector are not suitable for large-scale food production. Orbillion has redefined the process with three key advantages:

1. Real Muscle and Fat Cells

Orbillion’s bioware technology, powered by AI and computational modeling, enables direct scaling of non-GMO muscle and fat cells, saving time and millions in cost.

2. Biopharma Expertise

Orbillion’s co-founders bring deep expertise in biopharma scale-up, allowing them to redesign processes specifically for cultivated beef and food production—boosting efficiency and affordability.

3. Controlled Cellular Microenvironment

With advanced computational models, Orbillion creates a finely tuned environment for cell growth, reducing reliance on costly growth factors and setting a new standard for scalable cultivated meat.

The Future of Cultivated Beef

Orbillion’s success demonstrates that cultivated beef is moving rapidly from vision to reality. By combining non-GMO technology, AI-driven bioprocesses, and biopharma expertise, Orbillion is leading the way to make cultivated meat cost-effective, sustainable, and available to consumers worldwide.

Ready to Scale Your Climate Deep Tech Startup?

At Earth Venture Capital, we partner with bold founders building breakthrough climate deep tech solutions across Southeast Asia and beyond. If you’re tackling the toughest challenges in decarbonization, we want to hear from you.

👉Pitch to us and let’s explore how we can scale your innovation together.

👉 Connect with us on LinkedIn to stay updated on insights, investments, and opportunities.